SECURITY

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd.: 47 reported NSE/BSE deal sides from 2015-12-23 to 2025-10-20.

Reported purchases₹439.47 Cr

Reported sales₹1,091.55 Cr

Disclosed sides47

Recent disclosures

Date	Company	Participant	Side	Shares	Price	Reported value
2025-10-20NSE · Block	Dr. Lal Path Labs Ltd.	GOLDMAN SACHS BANK EUROPE SE - ODI	Buy	33,414	₹3160.00	₹10.56 Cr
2025-10-20NSE · Block	Dr. Lal Path Labs Ltd.	GOLDMAN SACHS (SINGAPORE) PTE - ODI	Sell	33,414	₹3160.00	₹10.56 Cr
2025-01-06NSE · Bulk	Dr. Lal Path Labs Ltd.	MULTI-MANAGER ICVC	Sell	434,943	₹2997.11	₹130.36 Cr
2022-10-25BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES CORE MSCI EMERGING MARKETS ETF	Buy	69,319	₹2550.90	₹17.68 Cr
2022-10-25BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES CORE EMERGING MARKETS MAURITIUS CO	Sell	69,319	₹2550.90	₹17.68 Cr
2022-10-25BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES MSCI INDIA SMALL-CAP ETF	Buy	12,949	₹2550.90	₹3.30 Cr
2022-10-25BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES INDIA SC MAURITIUS COMPANY	Sell	12,949	₹2550.90	₹3.30 Cr
2022-10-17BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES CORE EMERGING MARKETS MAURITIUS CO	Sell	69,250	₹2377.50	₹16.46 Cr
2022-10-17BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES CORE MSCI EMERGING MARKETS ETF	Buy	69,250	₹2377.50	₹16.46 Cr
2022-10-17BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES MSCI INDIA SMALL-CAP ETF	Buy	12,934	₹2377.50	₹3.08 Cr
2022-10-17BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES INDIA SC MAURITIUS COMPANY	Sell	12,934	₹2377.50	₹3.08 Cr
2022-10-11BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES CORE MSCI EMERGING MARKETS ETF	Buy	45,074	₹2374.50	₹10.70 Cr
2022-10-11BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES CORE EMERGING MARKETS MAURITIUS CO	Sell	45,074	₹2374.50	₹10.70 Cr
2022-10-11BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES MSCI INDIA SMALL-CAP ETF	Buy	8,419	₹2374.50	₹2.00 Cr
2022-10-11BSE · Block	Dr. Lal Path Labs Ltd.	ISHARES INDIA SC MAURITIUS COMPANY	Sell	8,419	₹2374.50	₹2.00 Cr